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Résumé en
anglais
Olfactomedin-4 (OLFM4, OLM4) is a 72 kDa secreted glycoprotein belonging to
the olfactomedin family. The OLFM4 gene expression is regulated by the
transcription factors NF-kappa B and AP-1, and the OLM4 functions are poorly
understood. OLM4 has been described as being able to interact with cell surface
proteins such as lectins and concanavalin-A suggesting that one function of OLM4
is to regulate cell adhesion and migration. OLM4 is a marker for intestinal stem
cells and is expressed at the bottom of the intestinal crypts. Expression of OLM4
during tumor development showed that OLM4 expression is increased in the early
stages of tumor initiation. As OLM4 is a secreted protein, it is a prime candidate
for biomarker research for tumor detection or progression. Levels of circulating
OLM4 were significantly higher in patients with gastric, colorectal, and pancreatic
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